Discover

AVTR
Avantor, Inc.
7.90
9800 x 7.73
6200 x 7.86
bid
ask
+
0.14
1.80%
8000 @ 04:00 PM
7.95 +0.05 (0.63%)
Ytd -31.06%
1y -49.03%
7.59
day range
7.92
7.41
52 week range
15.60
Open 7.76 Prev Close 7.76 Low 7.59 High 7.92 Mkt Cap 5.39B
Vol 8.23M Avg Vol 11.05M EPS -0.79 P/E N/A Forward P/E 9.09
Beta 1.00 Short Ratio 4.47 Inst. Own 103.76% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 04-29 50-d Avg 8.30 200-d Avg 11.37 1yr Est 10.58
Earning
Date For Estimate Reported Surprise surprise %
2026-04-29 2026-03 0.16 N/A N/A N/A
2026-02-11 2025-12 0.21 0.22 0.01 4.76%
2025-10-29 2025-09 0.23 N/A N/A N/A
2025-10-29 2025-09 0.23 0.22 -0.01 -4.35%
2025-08-01 2025-06 0.25 N/A N/A N/A
2025-08-01 2025-06 0.25 0.24 -0.01 -4.00%
Upgrade / Downgrade
Date Firm Action From To
2026-04-15 Barclays Upgrade Underweight Underweight
2026-04-06 Evercore ISI Group Upgrade In-Line In-Line
2026-03-06 Barclays Downgrade Equal-Weight Underweight
2026-02-13 Wells Fargo Upgrade Overweight Overweight
2026-02-12 Citigroup Upgrade Neutral Neutral
2026-02-12 Barclays Upgrade Equal-Weight Equal-Weight
Profile
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Insider Holder
Date Name Relation Quantity Description
2026-02-18 BLENN MARY Chief Operating Officer 253.38K Stock Award(Grant)
2026-02-18 GOURDIER BENOIT Officer 365.89K Stock Award(Grant)
2026-02-18 HANKAMER BRITTANY Officer 250.73K Stock Award(Grant)
2026-02-18 JONES R BRENT Chief Financial Officer 422.59K Stock Award(Grant)
2026-02-18 LIGNER EMMANUEL Chief Executive Officer 767.14K Stock Award(Grant)
2026-03-09 MEHRA SANJEEV K Director 0.00 Purchase
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Dodge & Cox Inc. 117.07M 924.81M 17.16%
2025-12-30 Vanguard Group Inc 64.90M 512.75M 9.52%
2025-12-30 Blackrock Inc. 59.60M 470.82M 8.74%
2025-12-30 Barrow, Hanley Mewhinney & Strauss, LLC 33.29M 262.97M 4.88%
2025-12-30 T. Rowe Price Investment Management, Inc. 32.13M 253.84M 4.71%
2025-12-30 Wellington Management Group, LLP 23.44M 185.15M 3.44%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 Dodge & Cox Funds-Dodge & Cox Stock Fund 74.87M 591.49M 10.98%
2026-02-27 iShares Trust-iShares Core S&P Mid-Cap ETF 22.01M 173.86M 3.23%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 21.54M 170.14M 3.16%
2026-01-30 VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund 20.48M 161.80M 3.00%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 15.47M 122.20M 2.27%
2025-12-30 T. Rowe Price Mid-Cap Growth Fund, Inc. 15.41M 121.72M 2.26%